Annexon Stock Investor Sentiment

ANNX Stock  USD 4.85  0.02  0.41%   
Slightly above 64% of Annexon's investor base is looking to short. The analysis of the overall investor sentiment regarding Annexon suggests that many traders are alarmed. Annexon's investing sentiment can be driven by a variety of factors including economic data, Annexon's earnings reports, geopolitical events, and overall market trends.
  

Annexon Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Annexon can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at thelincolnianonline.com         
Annexon Given Overweight Rating at Cantor Fitzgerald
news
over a year ago at news.google.com         
XBiotech stock jumps on 80M buyback offer - Seeking Alpha
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635
Yahoo News
over a year ago at news.google.com         
May MDA Breakout StocksETFs Week 20 - 2023 High-Frequency ... - Seeking Alpha
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Q2 2023 Earnings Estimate for Annexon, Inc. Issued By HC Wainwright
news
over a year ago at news.google.com         
Does Bellerophon Therapeutics Inc Have What it Takes to be in Your Portfolio Tuesday - InvestorsObse...
Google News at Macroaxis
over a year ago at investing.com         
Annexon earnings missed by 51.48, revenue was in line with estimates
Investing News at Macroaxis
over a year ago at finance.yahoo.com         
Annexon Reports First Quarter 2023 Financial Results and Highlights Recent Pipeline Progress
Yahoo News
over a year ago at thelincolnianonline.com         
Annexon, Inc. Short Interest Up 11.5 percent in April
news
over a year ago at news.google.com         
Is Teva Pharmaceutical Industries Ltd Stock Over or Undervalued - InvestorsObserver
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Annexon, Inc. Short Interest Update
news
over a year ago at news.google.com         
Annexon Stock Attractive, Below-Radar, Undervalued NASDAQ ... - Seeking Alpha
Google News at Macroaxis
over a year ago at news.google.com         
Annexon, Inc. Sees Significant Increase in Short ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
InflaRx prices 40M offering - Seeking Alpha
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Annexon Biosciences to Participate in the 22nd Annual Needham Virtual Healthcare Conference
Yahoo News
Far too much social signal, news, headlines, and media speculation about Annexon that are available to investors today. That information is available publicly through Annexon media outlets and privately through word of mouth or via Annexon internal channels. However, regardless of the origin, that massive amount of Annexon data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Annexon news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Annexon relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Annexon's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Annexon alpha.

Annexon Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 4500 shares by Ted Yednock of Annexon at 7.1 subject to Rule 16b-3
09/19/2024
2
Annexon Trading 4.7 percent Higher - Time to Buy - MarketBeat
10/08/2024
3
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635
10/16/2024
4
Were Hopeful That Annexon Will Use Its Cash Wisely
10/21/2024
5
Disposition of 36050 shares by Love Douglas of Annexon at 1.8501 subject to Rule 16b-3
10/30/2024
6
Annexon Biosciences to Present at the Jefferies London Healthcare Conference
11/13/2024
7
Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones
11/14/2024
8
Analysts Set Annexon, Inc. Target Price at 15.80
11/15/2024
9
Annexon Stock Price Up 5.7 percent Should You Buy
11/26/2024
10
Acquisition by Carson William H. of 3200 shares of Annexon at 5.33 subject to Rule 16b-3
12/02/2024
11
Short Interest in Annexon, Inc. Declines By 8.1
12/03/2024
12
Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting
12/05/2024

Additional Tools for Annexon Stock Analysis

When running Annexon's price analysis, check to measure Annexon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexon is operating at the current time. Most of Annexon's value examination focuses on studying past and present price action to predict the probability of Annexon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexon's price. Additionally, you may evaluate how the addition of Annexon to your portfolios can decrease your overall portfolio volatility.